NCT07757867Completed
Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata
Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata: A Pilot Randomized Controlled Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Tanta University
- Participants (registry)
- 80
- Start
- October 2022
- Primary completion
- October 2024
- Study completion
- October 2024
- Last registry update
- August 2026
- Countries
- Egypt
Conditions studied: Microneedling-Assisted Delivery, Cetirizine, Latanoprost, Alopecia Areata
Interventions: Cetirizine (Zyrtec), Latanoprost, Triamcinolone Acetonide, Microneedling only
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.